Treatment with adavosertib also resulted in increases in tumour cytokine and chemokine gene expression consistent with increased immune priming and activation.Despite the impact of adavosertib on T cell proliferation, anti-tumour efficacy studies in a murine syngeneic tumour model do not show antagonism of anti-PDL1 activity by adavosertib. Here, CD274 is linked to neoplasm.